Clinical Nutrition for Diabetes Care Market Report 2026

The clinical nutrition for diabetes care market size has grown strongly in recent years. It will grow from $3.17 billion in 2025 to $3.42 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to increasing prevalence of diabetes worldwide, expansion of diabetes management programs, rising awareness of nutritional therapy in diabetes care, growth in institutional nutrition services, availability of specialized diabetic nutrition products.

The clinical nutrition for diabetes care market size is expected to see strong growth in the next few years. It will grow to $4.44 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing focus on personalized diabetes management, rising adoption of low-carbohydrate and fiber-enriched nutrition, expansion of remote patient monitoring solutions, growing integration of nutrition with digital diabetes care platforms, increasing demand for preventive nutrition strategies. Major trends in the forecast period include increasing adoption of personalized diabetes nutrition programs, rising demand for diabetic-specific oral and enteral formulas, growing use of digital nutrition monitoring tools, expansion of home-based diabetes nutrition management, enhanced focus on glycemic-control-oriented nutrition.

The increasing prevalence of diabetes is expected to drive the growth of the clinical nutrition for diabetes care market in the coming years. Diabetes is a group of metabolic disorders marked by persistently high blood glucose levels, resulting either from insufficient insulin production or the body’s inability to effectively use insulin. The rising incidence of diabetes is influenced by factors such as sedentary lifestyles, unhealthy dietary habits, genetic susceptibility, and aging populations. Clinical nutrition for diabetes care plays a vital role in supporting diabetes management by offering personalized dietary plans that help regulate blood sugar levels, support weight control, and reduce the risk of long-term complications. For instance, in June 2024, according to the National Health Service, a UK-based government department, the number of individuals under 40 living with diabetes increased from 173,166 in 2022 to 216,440 in 2023. This sharp rise highlights a concerning trend among younger age groups and reflects the rapid growth of diabetes prevalence. Therefore, the increasing prevalence of diabetes is contributing to the expansion of the clinical nutrition for diabetes care market.

Major companies operating in the clinical nutrition for diabetes care market are focusing on the development of specialized nutritional formulations designed to meet the specific dietary requirements of individuals with diabetes, including effective blood sugar management and overall health support. Specialized nutrition products are formulated to provide balanced nutrition, help control glucose levels, and promote general well-being in diabetes patients. For example, in March 2024, Abbott Healthcare Pvt Ltd., a US-based pharmaceutical manufacturer, launched Ensure Diabetes Care, a nutritional supplement drink developed specifically for people with diabetes. Ensure Diabetes Care is scientifically formulated with a low glycemic index and includes a combination of high-quality protein, complex carbohydrates, dietary fiber, and essential vitamins and minerals to support effective diabetes management.

In June 2023, Abbott Laboratories, a US-based healthcare and medical devices company offering specialized nutritional products, entered into a partnership with the American Diabetes Association. Through this collaboration, Abbott Laboratories and the American Diabetes Association aim to advance innovative solutions for diabetes management and care. The partnership focuses on developing advanced technologies, educational initiatives, and support systems to empower individuals living with diabetes. The American Diabetes Association is a US-based nonprofit organization dedicated to public education and advocacy related to diabetes.

Major companies operating in the clinical nutrition for diabetes care market are Pfizer Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Roche Holdings Inc., Medtronic plc, Danone SA, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd, Baxter International Inc., B. Braun Melsungen AG, Glanbia plc, Perrigo Company plc, MannKind Corp, Omada Health, Fresenius Kabi AG, Hormel Health Labs Inc, Kate Farms Inc, Meiji Holdings Co Ltd, Otsuka Holdings Co Ltd, Herbalife Nutrition Ltd.

North America was the largest region in the clinical nutrition for diabetes care market in 2025. The regions covered in the clinical nutrition for diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical nutrition for diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the clinical nutrition for diabetes care market by increasing costs of imported nutritional ingredients, specialized formulations, medical packaging, and processing equipment. Healthcare institutions and nutrition suppliers in North America and Europe are most affected due to reliance on imported clinical nutrition inputs, while Asia-Pacific faces cost pressures in scaling diabetic nutrition production. These tariffs are raising treatment costs and impacting affordability. However, they are also encouraging local ingredient sourcing, domestic manufacturing of diabetic nutrition products, and innovation in cost-effective nutritional formulations.

The clinical nutrition for diabetes care market research report is one of a series of new reports that provides clinical nutrition for diabetes care market statistics, including clinical nutrition for diabetes care industry global market size, regional shares, competitors with a clinical nutrition for diabetes care market share, detailed clinical nutrition for diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition for diabetes care industry. This clinical nutrition for diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical nutrition for diabetes care involves providing specialized dietary guidance and nutritional support to individuals managing diabetes. This approach includes personalized nutritional assessments, structured meal planning, and education focused on carbohydrate management, glycemic control, and lifestyle modifications. The primary goal is to optimize nutritional intake, maintain stable blood glucose levels, prevent diabetes-related complications, and improve overall health outcomes.

The main products used in clinical nutrition for diabetes care include oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition in this market consists of dietary supplements, beverages, or foods consumed by mouth to meet the nutritional requirements of people with diabetes while supporting effective blood sugar management. These products are used across adult and pediatric patient groups and are distributed through multiple channels, including online platforms, retail outlets, and institutional sales.

The clinical nutrition for diabetes care market consists of revenues earned by entities by providing services such as medical nutrition therapy, dietary counseling, and diabetes self-management education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical nutrition for diabetes care market also includes sales of oral nutrition supplements, enteral nutrition, glucose control formulas, and low-glycemic index foods. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.